MODERATOR
:
SPEAKER
(S):
Dr. Harvey Alter, MD, Chief, Clinical Studies, Dept. Transfusion Medicine, National Institutes of Health
Roger Dodd, PhD, Vice President, R & D, American Red Cross Holland Laboratory
Current Status of Screening Donors for HAV and B19 Infection
John Roback, MD, PhD, Associate Professor, Emory Hospital
Description
In a slide/lecture format, experts in transfusion-transmitted diseases (TTD) will place in context the status of hepatitis A, hepatitis E, parvovirus B19 and cytomegalovirus to prepare the audience for developments in our response to mitigation of these diseases in the future.
-
Examine the potential importance of hepatitis E to transfusion medicine.
-
Explain the current status of testing for parvovirus B19 and hepatitis A to blood collection facilities.
-
Review the current status of cytomegalovirus-reduced-risk safe transfusion practices.
CE Category | CE Value |
---|
California Clinical Laboratory Personnel |
1.5 |
California Nurse |
1.8 |
Florida Laboratory Personnel |
1.8 |
General Attendee |
1.5 |
Physician |
1.5 |
Please note: Continuing education (CE) credit is available for online offerings only. Individuals that purchase CD-ROMs will not receive CE credit for the programs they view.